tradingkey.logo

Anebulo rises as it weighs going-private deal after getting fresh options

ReutersSep 12, 2025 1:34 PM

Shares of drug developer Anebulo Pharmaceuticals ANEB.O rise 16.9% to $2.35 in early morning trading

Anebulo Pharmaceuticals says it is still considering a plan to go private after it first announced it in July 2025, but has also received interest from possible buyers and partners

The company's board will review different options to maximize shareholder value, including the going-private deal with a reverse stock split, a potential sale of its assets, or a merger, the company says

As of last close, ANEB was down 19.6% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI